Capecitabine is a revolutionary oral chemotherapy medication used to treat various cancers, including colorectal and breast cancer. As a prodrug, it transforms into 5-fluorouracil (5-FU) within cancer cells, directly targeting and disrupting their DNA synthesis. This targeted approach minimizes damage to healthy tissues, leading to fewer side effects compared to traditional intravenous chemotherapy. Capecitabine’s oral formulation allows patients to take their treatment at home, offering convenience and improved quality of life.

A trusted Capecitabine manufacturer ensures the production of high-quality, reliable formulations that meet stringent global standards. With precision manufacturing and adherence to regulatory guidelines, reputable manufacturers play a vital role in making Capecitabine accessible to patients worldwide.